BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10803752)

  • 1. Formation of calcium pyrophosphate crystals: biologic implications.
    Rosenthal AK
    Curr Opin Rheumatol; 2000 May; 12(3):219-22. PubMed ID: 10803752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease.
    Hirose J; Ryan LM; Masuda I
    Arthritis Rheum; 2002 Dec; 46(12):3218-29. PubMed ID: 12483726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin promotes pathologic mineralization in articular cartilage.
    Rosenthal AK; Gohr CM; Uzuki M; Masuda I
    Matrix Biol; 2007 Mar; 26(2):96-105. PubMed ID: 17123806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease.
    Yamakawa K; Iwasaki H; Masuda I; Ohjimi Y; Honda I; Iyama K; Shono E; Naito M; Kikuchi M
    J Rheumatol; 2002 Aug; 29(8):1746-53. PubMed ID: 12180739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histochemical localization of calcium with potassium pyroantimonate in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K
    Clin Orthop Relat Res; 1991 Mar; (264):286-94. PubMed ID: 1705190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of chondrocyte production of extracellular inorganic pyrophosphate.
    Costello JC; Ryan LM
    Curr Opin Rheumatol; 2004 May; 16(3):268-72. PubMed ID: 15103256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histologic localization of lipid in the articular tissues in calcium pyrophosphate dihydrate crystal deposition disease.
    Ohira T; Ishikawa K; Masuda I; Yokoyama M; Honda I
    Arthritis Rheum; 1988 Aug; 31(8):1057-62. PubMed ID: 2457374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular matrix changes regulate calcium crystal formation in articular cartilage.
    Kalya S; Rosenthal AK
    Curr Opin Rheumatol; 2005 May; 17(3):325-9. PubMed ID: 15838245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of calcium-containing crystals to cartilage degradation and synovial inflammation in osteoarthritis.
    Liu YZ; Jackson AP; Cosgrove SD
    Osteoarthritis Cartilage; 2009 Oct; 17(10):1333-40. PubMed ID: 19447216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro models of calcium crystal formation.
    Gohr C
    Curr Opin Rheumatol; 2004 May; 16(3):263-7. PubMed ID: 15103255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of ANK protein expression in joint tissue in calcium pyrophosphate dihydrate crystal deposition disease.
    Uzuki M; Sawai T; Ryan LM; Rosenthal AK; Masuda I
    J Rheumatol; 2014 Jan; 41(1):65-74. PubMed ID: 24293574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the effect of transforming growth factor beta 1 on pyrophosphate elaboration from various articular tissues.
    Rosenthal AK; McCarty BA; Cheung HS; Ryan LM
    Arthritis Rheum; 1993 Apr; 36(4):539-42. PubMed ID: 7681284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium pyrophosphate dehydrate crystal deposition in the ligamentum flavum of the cervical spine: histopathological and immunohistochemical findings.
    Mwaka ES; Yayama T; Uchida K; Kobayashi S; Kokubo Y; Nakajima H; Sato R; Orwotho NT; Baba H
    Clin Exp Rheumatol; 2009; 27(3):430-8. PubMed ID: 19604435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium pyrophosphate crystal deposition in hyaline cartilage. Ultrastructural analysis and implications for pathogenesis.
    Pritzker KP; Cheng PT; Renlund RC
    J Rheumatol; 1988; 15(5):828-35. PubMed ID: 2845077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid stimulates pyrophosphate elaboration by cartilage and chondrocytes.
    Rosenthal AK; Henry LA
    Calcif Tissue Int; 1996 Aug; 59(2):128-33. PubMed ID: 8687982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of articular calcium-containing crystals by synchrotron FTIR.
    Rosenthal AK; Mattson E; Gohr CM; Hirschmugl CJ
    Osteoarthritis Cartilage; 2008 Nov; 16(11):1395-402. PubMed ID: 18472285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of calcium pyrophosphate dihydrate crystal formation in articular cartilage vesicles and cartilage by phosphocitrate.
    Cheung HS; Kurup IV; Sallis JD; Ryan LM
    J Biol Chem; 1996 Nov; 271(45):28082-5. PubMed ID: 8910421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic calcium pyrophosphate dihydrate (CPPD) crystal deposition disease in a young male patient: a case report.
    Ahn JK; Kim HJ; Kim EH; Jeon CH; Cha HS; Ha CW; Ahn JM; Koh EM
    J Korean Med Sci; 2003 Dec; 18(6):917-20. PubMed ID: 14676457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium pyrophosphate dihydrate crystal deposition and other crystal deposition diseases.
    Pritzker KP
    Curr Opin Rheumatol; 1994 Jul; 6(4):442-7. PubMed ID: 8068517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanobiological implications of articular cartilage crystals.
    Carlson AK; McCutchen CN; June RK
    Curr Opin Rheumatol; 2017 Mar; 29(2):157-162. PubMed ID: 27941391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.